ARCT · Company research
Arcturus Therapeutics Holdings Inc. Common Stock (ARCT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 13 | $393,658,550 | 202175550.00 | 39.2571428571428571 | — | — | 133.0376985468063535 | 2.2912701969640529 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.